Unlabelled: The aim was to evaluate the correlation of intestinal microflora with indicators of lipid metabolism and the possibility of its correcting with sporobakterin.

Material And Methods: 38 patients from gastroenterological department (men - 18 women - 20, average age - 54,00 +/- 13,59 years), trapped in a random 5% sample. Were assessed the state of the luminal microflora in the large intestine and total cholesterol, b-lipoprotein (b-PL) and HDL in serum levels. Fence, preparation and sowing of faeces were carried out according to the methodical recommendations of N. M. Gracheva et al. (1986). Counting and smear from the colonies of one species were made after a day of incubation. Lipid fraction of serum was evaluated on biochemical analyzer Cobas Integra 400 (Roche, Switzerland). 15 patients with intestinal disorders of microbiocenosis and hypercholesterolemia, was conducted drug treatment with "Sporobakterin liquid, a suspension for oral use" (OOO "Bacor", Russia) for a recommended scheme. Were assessed serum levels of total cholesterol, HDL, and beta-LP, composition of intestinal microflora, the body mass before and after treatment. Statistical analysis was conducted using methods of variation statistics.

Results: it was revealed a positive effect of the sporobakterin on intestinal microflora and statistically significant reduction in total cholesterol and b-LP, a tendency to body weight reduce.

Conclusion: The results indicated the influence of intestinal microflora on the atherogenic fractions of serum and the possibility of their correction with a sporobakterin.

Download full-text PDF

Source

Publication Analysis

Top Keywords

intestinal microflora
16
total cholesterol
12
patients intestinal
8
serum levels
8
intestinal
6
microflora
5
[sporobakterin impact
4
impact atherogenic
4
atherogenic dyslipidemia
4
dyslipidemia patients
4

Similar Publications

Unregulated pig farming practices expose pigs to fecal sewage and antibiotic stress, which are common health risk factors. Thus, its effects on the animals' intestinal microflora were investigated herein. In total, 2,315,563 high-quality sequences were obtained via amplitude sequencing and, after OUT clustering, the fecal sewage group was identified to have the highest number and the antibiotic exposure group the lowest.

View Article and Find Full Text PDF

Necrotizing enterocolitis (NEC) is a devastating disease of the neonatal gastrointestinal tract. Volatile organic compounds (VOCs), odoriferous compounds released as a byproduct of bacterial metabolism, can be used as a proxy for gut health. We hypothesized that patients with NEC would have different microbial profiles and elicit different VOC signatures as assessed by gas chromatography/mass spectrometry (GC/MS) or an electronic nose compared to controls.

View Article and Find Full Text PDF

Treatment with antibiotics is a major risk factor for infection, likely due to depletion of the gastrointestinal microbiota. Two microbiota-mediated mechanisms thought to limit colonization include the conversion of conjugated primary bile salts into secondary bile salts toxic to growth and competition between the microbiota and for limiting nutrients. Using a continuous flow model that simulates the nutrient conditions of the distal colon, we investigated how treatment with 6 clinically used antibiotics influenced susceptibility to infection in 12 different microbial communities cultivated from healthy individuals.

View Article and Find Full Text PDF

is a major cause of nosocomial diarrhea. As current antibiotic treatment failures and recurrence of infections are highly frequent, alternative strategies are needed for the treatment of this disease. This study explores the use of bacteriocins, specifically lacticin 3147 and pediocin PA-1, which have reported inhibitory activity against .

View Article and Find Full Text PDF

Advancing microbiome-gut-brain axis science requires systematic, rational and translational approaches to bridge the critical knowledge gaps currently preventing full exploitation of the gut microbiome as a tractable therapeutic target for gastrointestinal, mental and brain health. Current research is still marked by many open questions that undermine widespread application to humans. For example, the lack of mechanistic understanding of probiotic effects means it remains unclear why even apparently closely related strains exhibit different effects in vivo.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!